Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2611 | 2196 | 42.0 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
188 | 3 | DERMATOLOGY//CONTACT DERMATITIS//PSORIASIS | 55369 |
551 | 2 | PSORIASIS//PSORIATIC ARTHRITIS//DERMATOLOGY | 14610 |
2611 | 1 | PSORIASIS//EFALIZUMAB//USTEKINUMAB | 2196 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PSORIASIS | authKW | 1846329 | 41% | 15% | 893 |
2 | EFALIZUMAB | authKW | 661469 | 3% | 65% | 73 |
3 | USTEKINUMAB | authKW | 565678 | 4% | 47% | 87 |
4 | ALEFACEPT | authKW | 485322 | 2% | 73% | 48 |
5 | INVEST DERMATOL | address | 248117 | 3% | 31% | 57 |
6 | ETANERCEPT | authKW | 234026 | 7% | 11% | 152 |
7 | SECUKINUMAB | authKW | 227048 | 2% | 47% | 35 |
8 | DERMATOL | address | 190753 | 52% | 1% | 1152 |
9 | BIOLOGICS | authKW | 175357 | 6% | 10% | 123 |
10 | BRODALUMAB | authKW | 168508 | 1% | 61% | 20 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 147084 | 62% | 1% | 1357 |
2 | Immunology | 1381 | 14% | 0% | 298 |
3 | Pharmacology & Pharmacy | 413 | 11% | 0% | 231 |
4 | Medicine, Research & Experimental | 373 | 6% | 0% | 132 |
5 | Allergy | 181 | 2% | 0% | 34 |
6 | Rheumatology | 110 | 2% | 0% | 35 |
7 | Pathology | 106 | 3% | 0% | 59 |
8 | Medicine, General & Internal | 47 | 4% | 0% | 87 |
9 | Integrative & Complementary Medicine | 10 | 0% | 0% | 9 |
10 | Health Care Sciences & Services | 8 | 1% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INVEST DERMATOL | 248117 | 3% | 31% | 57 |
2 | DERMATOL | 190753 | 52% | 1% | 1152 |
3 | INVESTIGAT DERMATOL | 153535 | 1% | 41% | 27 |
4 | MURDOUGH FAMILY PSORIASIS | 60230 | 1% | 33% | 13 |
5 | MILSTEIN MED PROGRAM | 41710 | 0% | 100% | 3 |
6 | PROB MED | 41710 | 0% | 100% | 3 |
7 | CENT DERMATOL | 37073 | 0% | 67% | 4 |
8 | PSORIASIS | 35833 | 1% | 18% | 14 |
9 | SALFORD ROYAL HOSP | 32374 | 1% | 14% | 17 |
10 | IMMUNOL BIOMARKERS | 31775 | 0% | 57% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 51501 | 3% | 7% | 55 |
2 | JOURNAL OF DERMATOLOGICAL TREATMENT | 49304 | 3% | 5% | 69 |
3 | BRITISH JOURNAL OF DERMATOLOGY | 42653 | 8% | 2% | 184 |
4 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 31142 | 4% | 3% | 90 |
5 | JOURNAL OF DRUGS IN DERMATOLOGY | 26031 | 3% | 3% | 56 |
6 | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 19460 | 6% | 1% | 131 |
7 | AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 18119 | 1% | 4% | 31 |
8 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 16443 | 5% | 1% | 112 |
9 | SEMINARS IN CUTANEOUS MEDICINE AND SURGERY | 15350 | 1% | 4% | 29 |
10 | EXPERIMENTAL DERMATOLOGY | 10711 | 2% | 2% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PSORIASIS | 1846329 | 41% | 15% | 893 | Search PSORIASIS | Search PSORIASIS |
2 | EFALIZUMAB | 661469 | 3% | 65% | 73 | Search EFALIZUMAB | Search EFALIZUMAB |
3 | USTEKINUMAB | 565678 | 4% | 47% | 87 | Search USTEKINUMAB | Search USTEKINUMAB |
4 | ALEFACEPT | 485322 | 2% | 73% | 48 | Search ALEFACEPT | Search ALEFACEPT |
5 | ETANERCEPT | 234026 | 7% | 11% | 152 | Search ETANERCEPT | Search ETANERCEPT |
6 | SECUKINUMAB | 227048 | 2% | 47% | 35 | Search SECUKINUMAB | Search SECUKINUMAB |
7 | BIOLOGICS | 175357 | 6% | 10% | 123 | Search BIOLOGICS | Search BIOLOGICS |
8 | BRODALUMAB | 168508 | 1% | 61% | 20 | Search BRODALUMAB | Search BRODALUMAB |
9 | IXEKIZUMAB | 167288 | 1% | 63% | 19 | Search IXEKIZUMAB | Search IXEKIZUMAB |
10 | APREMILAST | 163926 | 1% | 47% | 25 | Search APREMILAST | Search APREMILAST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DI MEGLIO, P , VILLANOVA, F , NESTLE, FO , (2014) PSORIASIS.COLD SPRING HARBOR PERSPECTIVES IN MEDICINE. VOL. 4. ISSUE 8. P. - | 98 | 48% | 12 |
2 | FRAMPTON, JE , PLOSKER, GL , (2009) EFALIZUMAB A REVIEW OF ITS USE IN THE MANAGEMENT OF CHRONIC MODERATE-TO-SEVERE PLAQUE PSORIASIS.AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. VOL. 10. ISSUE 1. P. 51-72 | 59 | 91% | 15 |
3 | MANSOURI, B , PATEL, M , MENTER, A , (2013) BIOLOGICAL THERAPIES FOR PSORIASIS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 13. ISSUE 12. P. 1715 -1730 | 75 | 61% | 7 |
4 | LOWES, MA , SUAREZ-FARINAS, M , KRUEGER, JG , (2014) IMMUNOLOGY OF PSORIASIS.ANNUAL REVIEW OF IMMUNOLOGY, VOL 32. VOL. 32. ISSUE . P. 227-255 | 56 | 43% | 126 |
5 | CLINE, A , HILL, D , LEWALLEN, R , FELDMAN, SR , (2016) CURRENT STATUS AND FUTURE PROSPECTS FOR BIOLOGIC TREATMENTS OF PSORIASIS.EXPERT REVIEW OF CLINICAL IMMUNOLOGY. VOL. 12. ISSUE 12. P. 1273 -1287 | 64 | 63% | 0 |
6 | TSAI, YC , TSAI, TF , (2016) A REVIEW OF CLINICAL TRIALS OF BIOLOGIC AGENTS AND SMALL MOLECULES FOR PSORIASIS IN ASIAN SUBJECTS.GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. VOL. 151. ISSUE 4. P. 412 -431 | 41 | 87% | 1 |
7 | BURNESS, CB , MCKEAGE, K , (2015) ADALIMUMAB: A REVIEW IN CHRONIC PLAQUE PSORIASIS.DRUGS. VOL. 75. ISSUE 18. P. 2119 -2130 | 47 | 78% | 2 |
8 | JOHNSON-HUANG, LM , LOWES, MA , KRUEGER, JG , (2012) PUTTING TOGETHER THE PSORIASIS PUZZLE: AN UPDATE ON DEVELOPING TARGETED THERAPIES.DISEASE MODELS & MECHANISMS. VOL. 5. ISSUE 4. P. 423-433 | 68 | 52% | 36 |
9 | MAHIL, SK , CAPON, F , BARKER, JN , (2016) UPDATE ON PSORIASIS IMMUNOPATHOGENESIS AND TARGETED IMMUNOTHERAPY.SEMINARS IN IMMUNOPATHOLOGY. VOL. 38. ISSUE 1. P. 11 -27 | 67 | 44% | 3 |
10 | LOWES, MA , RUSSELL, CB , MARTIN, DA , TOWNE, JE , KRUEGER, JG , (2013) THE IL-23/T17 PATHOGENIC AXIS IN PSORIASIS IS AMPLIFIED BY KERATINOCYTE RESPONSES.TRENDS IN IMMUNOLOGY. VOL. 34. ISSUE 4. P. 174-181 | 49 | 53% | 86 |
Classes with closest relation at Level 1 |